| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |